NCT06889766
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06889766
Title NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma (LauT1)
Acronym LauT1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Centre Hospitalier Universitaire Vaudois
Indications
Therapies
Age Groups: senior | adult
Covered Countries CHE


No variant requirements are available.